Ian Michael Estepan - 01 Mar 2026 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2026, 20:04:02 UTC
Prior SEC filing
02 Mar 2026
Next SEC filing
11 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan

Key filing fact

Ian Michael Estepan filed Form 4 for Sarepta Therapeutics, Inc. (SRPT) on 03 Mar 2026.

Key facts

  • This page summarizes Ian Michael Estepan's Form 4 filing for Sarepta Therapeutics, Inc. (SRPT).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Mar 2026, 20:04.

Change

  • Previous filing in this sequence was filed on 02 Mar 2026.
  • Current net transaction value: -$67,651.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001836254 Primary reporting owner

Estepan Ian Michael

Relationship
Chief Operating Officer
Address
215 FIRST STREET, SUITE 415, CAMBRIDGE
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan
Signature date
03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRPT transaction

Common Stock

Options Exercise

Transaction value
Shares
+8,125
Change %
+4%
Price
Shares after
208,875
Date
01 Mar 2026
Ownership
Direct
Footnotes
F1
SRPT transaction

Common Stock

Tax liability

Transaction value
$53,476
Shares
-3,301
Change %
-1.6%
Price
$16.20
Shares after
205,574
Date
02 Mar 2026
Ownership
Direct
Footnotes
F2
SRPT transaction

Common Stock

Tax liability

Transaction value
$14,175
Shares
-875
Change %
-0.43%
Price
$16.20
Shares after
204,699
Date
02 Mar 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SRPT transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
$0
Shares
-8,125
Change %
-100%
Price
$0.000000
Shares after
0
Date
01 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,125
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026.

Footnote F2

Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of a PSU award granted on March 1, 2024.

Footnote F3

Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .